News and Events


  • PERISCOPE project presented at Congress on Clinical Trials in Infection

    The conference “Clinical Trials in Infectious Disease - From Diagnosis to Clinic (CTIDC2018)” premiered in London, UK from July 02-03 2018. CTICD2018 was targeted at scientists and clinicians in the field of Infection, pharmaceutical, biomedical and medical device industries, clinical research organisations and research networks. The conference...

  • PERISCOPE EFPIA partners publish comment on IMI projects’ impact on vaccine development

    Since the launch of IMI2 in 2014, the intensified vaccine focus of the program has resulted in the support of 14 vaccine-focused project consortia – with PERISCOPE being one of them. Philippe Denoel (GSK) and Patricia Londono-Hayes (SP) as EFPIA representatives within our project have co-authored a comment that was recently published in NATURE...

  • PERISCOPE NEWSLETTER 4.0

    The PERISCOPE project has released its 4th newsletter including the latest updates on the project’s progress. You can download the fourth issue of the newsletter now. We hope that you will enjoy reading the latest news of PERISCOPE!

  • IMI is celebrating its 10th anniversary

    … and we are proud to be part of its success! See how IMI is working to overcome some of biggest medical challenges: http://bit.ly/IMITenYears  Further activites of IMI this year are the following big events: 27 June:  'IMI: celebrating 10 years of medical innovations' (jointly organised with the EC and EFPIA) – please note...

  • PERISCOPE annual meeting 2018 in Lyon

    This year’s annual meeting was loaded with dynamic scientific discussions, inspiring young researcher presentations and dedicated work group meetings. The project participants came together in Lyon, France from March 7-9, 2018 for a 2.5 day event hosted by Sanofi Pasteur.

  • EC consultation on “Strengthened cooperation against vaccine preventable diseases”

    The European Commission (EC) launched an open public consultation on possible activities for stronger EU cooperation against vaccine preventable diseases. The initiative shall be implemented in 2018 following feedback from interested individuals on 1) tackling vaccine hesitancy, 2) sustainable vaccine policies in the EU and 3) EU coordination,...

  • PERISCOPE NEWSLETTER 3.0

    The PERISCOPE project has released its 3rd newsletter including the latest updates on the project’s progress. You can download the third issue of the newsletter now. We hope that you will enjoy reading the latest news of PERISCOPE!

  • BERT study launched in The Netherlands

    The second PERISCOPE clinical study – the BERT study – carried out on behalf of the Dutch National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM) has started. In the first week of October, 2017, the first patient took part in the clinical study which is conducted at the Spaarne Gasthuis in...

  • TRANSVAC Open Call for Vaccine Development Services

    The EU infrastructure project TRANSVAC offers high-quality technical services free of charge to promote the development of prophylactic and therapeutic vaccines for both human and animal use. TRANSVAC aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal...

  • PERISCOPE workshop on the core B-cell and T-cell assays

    From September 13 – 15, 2017 a three day workshop on the development and standardisation of Bp-specific T-cell and B-cell ELISpot assays was held in the Netherlands. Organizer and host of the workshop was the PERISCOPE team at the Dutch National Institute for Public Health and the Environment (Rijksinstituut voor Volksgezondheid en Milieu, RIVM)...

  • PERISCOPE NEWSLETTER 2.0

    The PERISCOPE project has released its 2nd biannual newsletter including the latest updates on the project’s progress. You can download the second issue of the newsletter now. We hope that you will enjoy reading the project’s latest news!

  • First Clinical Site Preparation started

    The first PERISCOPE clinical study is about to start - on April 27th, 2017, the future team that will be involved in the implementation of the study came together for a site initiation visit at NIHR Wellcome Trust Clinical Research Facility in Southampton, UK. The study team discussed the trial protocol, the monitoring plan and requirements and...

  • PERISCOPE annual meeting 2017 in Prague

    From March 8-10 the PERISCOPE Consortium came together for its annual meeting in Prague (Czech Republic), the hometown of the project partner Institute of Microbiology of the ASCR, v. v. i. (IMIC), to discuss the project’s progress and future collaboration.

  • Third PERISCOPE Steering Committee Meeting

    On December 16, 2016, the Steering Committee of the PERISCOPE project came together in Leiden, NL for the third time to discuss the project’s progress and to align activities throughout the different work packages. All present work package leaders and co-leads from the industry partners summarized their activities to date and discussed overarching...

  • First PERISCOPE Newsletter out now!

    Click to read more...

  • PERISCOPE Kick-off Meeting

    From March 2nd to 4th, 2016, the PERISCOPE consortium came together in Dublin, Ireland for officially starting project activities that will now be continued for a total duration of 60 months. The Kick-off Meeting was hosted by PERISCOPE partner Kingston Mills from Trinity College Dublin and took place in the nearby Davenport Hotel located in the...